RESUMO
Acromegaly is characterized by chronic growth hormone hypersecretion. Cardiovascular alterations such as hypertension, left ventricular hypertrophy, cardiac rhythm disturbances and valvular disease are common in this disease and are the main cause of death. Control of acromegaly by surgery or pharmacotherapy has been shown to improve cardiovascular morbidity. We report a case of acromegalic myocardiopathy in a 59-year-old woman with dilated myocardiopathy who presented ventricular diameter and contractility normalization following medical treatment.
Assuntos
Acromegalia/complicações , Cardiomiopatia Dilatada/etiologia , Acromegalia/diagnóstico , Acromegalia/tratamento farmacológico , Adenoma/complicações , Adenoma/diagnóstico , Adenoma/tratamento farmacológico , Cardiomiopatia Dilatada/diagnóstico , Cardiomiopatia Dilatada/patologia , Síndrome do Túnel Carpal/complicações , Feminino , Doenças das Valvas Cardíacas/complicações , Humanos , Pessoa de Meia-Idade , Peptídeos Cíclicos/uso terapêutico , Neoplasias Hipofisárias/complicações , Neoplasias Hipofisárias/diagnóstico , Neoplasias Hipofisárias/tratamento farmacológico , Indução de Remissão , Síndromes da Apneia do Sono/complicações , Somatostatina/análogos & derivados , Somatostatina/uso terapêuticoRESUMO
La acromegalia es una enfermedad caracterizada por la hipersecreción crónica de hormona de crecimiento. Alteraciones cardiovasculares, como hipertensión, hipertrofia ventricular izquierda, alteraciones del ritmo cardíaco y valvulopatías son frecuentes en esta enfermedad y representan la principal causa de mortalidad. El control de la acromegalia mediante cirugía o tratamiento médico ha demostrado mejorar la morbilidad cardiovascular. Presentamos el caso de una miocardiopatía acromegálica en una mujer de 59 años con una miocardiopatía dilatada que presentó normalización del diámetro y la contractilidad ventricular tras tratamiento médico (AU)
Acromegaly is characterized by chronic growth hormone hypersecretion. Cardiovascular alterations such as hypertension, left ventricular hypertrophy, cardiac rhythm disturbances and valvular disease are common in this disease and are the main cause of death. Control of acromegaly by surgery or pharmacotherapy has been shown to improve cardiovascular morbidity. We report a case of acromegalic myocardiopathy in a 59-year-old woman with dilated myocardiopathy who presented ventricular diameter and contractility normalization following medical treatment (AU)
